Literature DB >> 8197781

Management of locally advanced breast cancer.

P I Borgen1.   

Abstract

The management of locally advanced breast cancer with single modality therapy has been associated with a high rate of systemic failure. A multimodality treatment strategy that includes induction cytotoxic chemotherapy, surgery, radiation therapy, and, possibly, hormonal ablation therapy is the current preferred management approach. As our knowledge and understanding of the mechanisms involved in mitogenic signal transduction improve, it is likely that less toxic, more efficacious agents will emerge.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8197781     DOI: 10.1007/bf00348196

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  50 in total

1.  CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY.

Authors:  C D Haagensen; A P Stout
Journal:  Ann Surg       Date:  1943-11       Impact factor: 12.969

2.  Radiation treatment of stage III mammary carcinoma: a review of 129 patients.

Authors:  A D Treurniet-Donker; W C Hop; S den Hoed-Sijtsema
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-11       Impact factor: 7.038

3.  Stage III and localized stage IV breast cancer: irradiation alone vs irradiation plus surgery.

Authors:  J Bedwinek; D V Rao; C Perez; J Lee; B Fineberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-01       Impact factor: 7.038

Review 4.  Combined modality therapy of locally advanced breast cancer. One institution's experience and a review of the literature.

Authors:  E Hu; F E Stockdale; B Turner; R W Carlson; J Levine; P Kushlan
Journal:  Anticancer Res       Date:  1987 Jul-Aug       Impact factor: 2.480

5.  Primary radiation therapy for locally advanced breast cancer.

Authors:  T Sheldon; D F Hayes; B Cady; L Parker; R Osteen; B Silver; A Recht; S Come; I C Henderson; J R Harris
Journal:  Cancer       Date:  1987-09-15       Impact factor: 6.860

6.  Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer.

Authors:  M De Lena; R Zucali; G Viganotti; P Valagussa; G Bonadonna
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

7.  Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer.

Authors:  P Gröhn; E Heinonen; P Klefström; J Tarkkanen
Journal:  Cancer       Date:  1984-08-15       Impact factor: 6.860

8.  Multimodal therapy for locally advanced breast cancer.

Authors:  M Morrow; A Braverman; W Thelmo; C K Sohn; J Sand; M Mora; T Forlenza; J Marti
Journal:  Arch Surg       Date:  1986-11

9.  Scientific basis for adjuvant and primary (neoadjuvant) chemotherapy.

Authors:  J H Goldie
Journal:  Semin Oncol       Date:  1987-03       Impact factor: 4.929

10.  Conservative treatment (chemotherapy/radiotherapy) of locally advanced breast cancer.

Authors:  M Héry; M Namer; M Moro; J L Boublil; C M LaLanne
Journal:  Cancer       Date:  1986-05-01       Impact factor: 6.860

View more
  1 in total

Review 1.  Locally advanced breast cancer in developing countries: the place of surgery.

Authors:  Justus P Apffelstaedt
Journal:  World J Surg       Date:  2003-06-06       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.